Editorial: The safety and efficacy of ustekinumab in anti-TNFα refractory pediatric inflammatory bowel disease

Saved in:
Bibliographic Details
Main Authors: Katelynn K. Ho, David L. Suskind, Ghassan T. Wahbeh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-03-01
Series:The Saudi Journal of Gastroenterology
Online Access:https://journals.lww.com/10.4103/sjg.sjg_384_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849737380031889408
author Katelynn K. Ho
David L. Suskind
Ghassan T. Wahbeh
author_facet Katelynn K. Ho
David L. Suskind
Ghassan T. Wahbeh
author_sort Katelynn K. Ho
collection DOAJ
format Article
id doaj-art-b2ba03a429bc407da6404d2bbe90be13
institution DOAJ
issn 1319-3767
1998-4049
language English
publishDate 2025-03-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series The Saudi Journal of Gastroenterology
spelling doaj-art-b2ba03a429bc407da6404d2bbe90be132025-08-20T03:06:56ZengWolters Kluwer Medknow PublicationsThe Saudi Journal of Gastroenterology1319-37671998-40492025-03-01312515210.4103/sjg.sjg_384_24Editorial: The safety and efficacy of ustekinumab in anti-TNFα refractory pediatric inflammatory bowel diseaseKatelynn K. HoDavid L. SuskindGhassan T. Wahbehhttps://journals.lww.com/10.4103/sjg.sjg_384_24
spellingShingle Katelynn K. Ho
David L. Suskind
Ghassan T. Wahbeh
Editorial: The safety and efficacy of ustekinumab in anti-TNFα refractory pediatric inflammatory bowel disease
The Saudi Journal of Gastroenterology
title Editorial: The safety and efficacy of ustekinumab in anti-TNFα refractory pediatric inflammatory bowel disease
title_full Editorial: The safety and efficacy of ustekinumab in anti-TNFα refractory pediatric inflammatory bowel disease
title_fullStr Editorial: The safety and efficacy of ustekinumab in anti-TNFα refractory pediatric inflammatory bowel disease
title_full_unstemmed Editorial: The safety and efficacy of ustekinumab in anti-TNFα refractory pediatric inflammatory bowel disease
title_short Editorial: The safety and efficacy of ustekinumab in anti-TNFα refractory pediatric inflammatory bowel disease
title_sort editorial the safety and efficacy of ustekinumab in anti tnfα refractory pediatric inflammatory bowel disease
url https://journals.lww.com/10.4103/sjg.sjg_384_24
work_keys_str_mv AT katelynnkho editorialthesafetyandefficacyofustekinumabinantitnfarefractorypediatricinflammatoryboweldisease
AT davidlsuskind editorialthesafetyandefficacyofustekinumabinantitnfarefractorypediatricinflammatoryboweldisease
AT ghassantwahbeh editorialthesafetyandefficacyofustekinumabinantitnfarefractorypediatricinflammatoryboweldisease